teleocidin b-4 has been researched along with novobiocin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaneko, Y; Kurokawa, K; Tsukamoto, A | 1 |
| Kaneko, Y; Oka, H; Toda, G | 1 |
2 other study(ies) available for teleocidin b-4 and novobiocin
| Article | Year |
|---|---|
Novobiocin modulates cytokeratin assembly and differentiation of human hepatoma cells induced by butyrate and teleocidin.
Topics: Acetylation; Butyrates; Butyric Acid; Carcinogens; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Cytoskeletal Proteins; Drug Synergism; Humans; Keratins; Liver Neoplasms; Lyngbya Toxins; Novobiocin; Peptide Fragments; Procollagen; Tumor Cells, Cultured | 1991 |
Effects of teleocidin on the morphology and c-myc expression of hepatoma cells which are not inhibited by protein kinase antagonists.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Butyrates; Cell Division; Diglycerides; Isoquinolines; Liver; Liver Neoplasms, Experimental; Lyngbya Toxins; Novobiocin; Piperazines; Protein Kinase Inhibitors; Proto-Oncogenes; Rats; Sulfonamides; Transcription, Genetic | 1987 |